AV

Ashish Verma

Active Director Director DIN 08713634
DIN 08713634 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Feb 2020
Shareholding value •••• Premium profile

About Ashish Verma

Data last updated:

Ashish Verma is a Director at Welnex Bio Private Limited (since 2020), Director at Medplex Biotech Private Limited (since 2022) and Director at Zenio Biotech Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma, Food And Beverages and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹5.35 Cr; the largest is Welnex Bio Private Limited at ₹3.42 Cr (FY 2025). Earlier, Ashish Verma was a Director at Iretus Biotech Private Limited (2021–2024) and Director at Stevels Pharma Limited (2021–2023).

DIN 08713634
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2020
Oldest Company Age 6 yrs
Largest company Welnex Bio Private Limited · ₹3.42 Cr (FY 2025)
Combined revenue ₹5.35 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Welnex Bio Private Limited U24290HR2020PTC085658
Director28 Feb 20202020₹3.42 Cr (FY 2025)Active
Medplex Biotech Private Limited U24302HR2022PTC102977
Director20 Apr 20222022₹1.05 Cr (FY 2025)Active
Zenio Biotech Private Limited U24303HR2020PTC091396
Director05 Dec 20202020₹88.1 Lakh (FY 2024)Active
Nedulix Biotech Private Limited U24290CH2021PTC044080
Director09 Dec 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iretus Biotech Private Limited U24290HR2021PTC099958
Director16 Dec 20212021₹2.14 Cr (FY 2025)Active
Stevels Pharma Limited U24230CH2004PLC027156
Director14 Dec 20212004₹52.4 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nedulix Biotech Private Limited
Welnex Bio Private Limited
Medplex Biotech Private Limited
Zenio Biotech Private Limited
Premium access

Shareholding and investment profile for Ashish Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Verma

Ashish Verma currently holds 4 directorships: Welnex Bio Private Limited (Director, since 28 Feb 2020, revenue ₹3.42 Cr (FY 2025)); Medplex Biotech Private Limited (Director, since 20 Apr 2022, revenue ₹1.05 Cr (FY 2025)); Zenio Biotech Private Limited (Director, since 05 Dec 2020, revenue ₹88.1 Lakh (FY 2024)); Nedulix Biotech Private Limited (Director, since 09 Dec 2021).

Ashish Verma was first appointed on 28 Feb 2020 as Director at Welnex Bio Private Limited. The most recent appointment on record is 20 Apr 2022 at Medplex Biotech Private Limited.

The 3 current companies of Ashish Verma that report revenue have a combined latest revenue of ₹5.35 Cr: Welnex Bio Private Limited ₹3.42 Cr (FY 2025); Medplex Biotech Private Limited ₹1.05 Cr (FY 2025); Zenio Biotech Private Limited ₹88.1 Lakh (FY 2024).

Ashish Verma held 2 earlier board appointments: Iretus Biotech Private Limited (Director, 16 Dec 2021 to 01 Aug 2024); Stevels Pharma Limited (Director, 14 Dec 2021 to 20 Jun 2023).

The current boards of Ashish Verma's companies include Naveen Chandara Suteri (Welnex Bio Private Limited), Ram Mahajan (Welnex Bio Private Limited), Priya Verma (Medplex Biotech Private Limited), Richa Chouhan (Zenio Biotech Private Limited), Neha (Nedulix Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available